bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.05.31.596792

Compensating functional connectivity changesdue to structural connectivity damage viamodifications of local dynamics

Abstract

Neurological pathologies as e.g. Alzheimers Disease or Multiple Sclerosis are often associated to neurodegenerative processes affecting the strength and the transmission speed of long-range inter-regional fiber tracts. Such degradation of Structural Connectivity impacts on large-scale brain dynamics and the associated Functional Connectivity, eventually perturbing network computations and cognitive performance. Functional Connectivity however is not bound to merely mirror Structural Connectivity, but rather reflects the complex coordinated dynamics of many regions. Here, using analytical characterizations of toy models and computational simulations connectome-base whole-brain models, we predict that suitable modulations of regional dynamics could precisely compensate for the effects of structural degradation, as if the original Structural Connectivity strengths and speeds of conduction were effectively restored. The required dynamical changes are widespread and aspecific (i.e. they do not need to be restricted to specific regions) so that they could be potentially implemented via neuromodulation or pharmacological therapy, globally shifting regional excitability and/or excitation/inhibition balance. Computational modelling and theory thus suggest that, in the future therapeutic interventions could be designed to "repair brain dynamics" rather than structure to boost functional connectivity without having to block or revert neurodegenerative processes. AUTHOR SUMMARYNeurological disorders affect Structural Connectivity, i.e. the wiring infrastructure interlinking distributed brain regions. Here we propose that the resulting disruptions in Functional Connectivity, i.e. inter-regional coordination and information sharing, could be compensated by modifying local dynamics so to effectively emulate the restoration of Structural Connectivity (but through a suitable "software patch" rather than by repairing the "hardware"). For simple toy models involving a few regions we can achieve an analytical understanding of how structural and dynamical changes jointly control Functional Connectivity. We then show that the concept of "effective connectome change" via modulation of dynamics robustly extend also to simulation of large-scale models embedding realistic whole-brain connectivity. We thus forecast that novel therapeutic strategies could be devised, targeting dynamics rather than neurodegenerative mechanisms.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Benitez-Stulz, S., Castro, S., Dumont, G., Gutkin, B., Battaglia, D.. 2024-06-01. Compensating functional connectivity changesdue to structural connectivity damage viamodifications of local dynamics. https://doi.org/10.1101/2024.05.31.596792

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗